Researchers suggest that MultiCell could potentially be used to discern early patterns of disease, such as in asthma.

Data from a disease model showed that HSV1 infection caused tau hyperphosphorylation, forming aggregates that trapped viral ...

Liver cells exposed to a high fat diet revert to an immature state that is more susceptible to cancer-causing mutations.

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Research revealed how bacteriophages use a tiny piece of genetic material to hijack bacterial cells and make more copies of themselves.

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

GEN lists the top five performing biotech stocks of 2025 and the five biotech stocks that fell the most during this past year, with brief explanations for the increases or declines.

Use this brand-new eBook from Cytiva to learn more about the oligonucleotide market as a whole and about the full workflow solutions available today. We hope you enjoy it!

Results open the door to therapies based on chronobiology, the branch of biology that studies how living organisms structure their physiological processes in time.

Samsung Biologics will acquire the Rockville assets for $280 million with closing anticipated toward the end of Q1 of 2026.

"Instead of just saying young women suffer from IBS, we wanted rigorous science explaining why," said co-senior author Holly Ingraham, PhD.

A new study shows how histones undergo correct chemical modifications during synthesis to guide new therapies.